Cronos vs Usana Health Sciences: revenue, profit, margins and growth compared
Cronos brought in $193.4M of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by +19.5% at Cronos and +8.3% at Usana Health Sciences on the year before, so Cronos grew faster. Cronos kept -4.9% of its revenue as net profit, Usana Health Sciences 1.2%. Free cash flow was $149K at Cronos and $8.5M at Usana Health Sciences.
Fiscal years as each company reports them; the two may end in different months.
Questions about Cronos and Usana Health Sciences
Which is bigger by revenue, Cronos or Usana Health Sciences?
Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $193.4M for Cronos in fiscal 2025.
Which keeps more of its revenue as profit, Cronos or Usana Health Sciences?
Cronos had a net margin of -4.9% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.
Which grew revenue faster, Cronos or Usana Health Sciences?
In their latest fiscal years revenue changed by +19.5% at Cronos and +8.3% at Usana Health Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.